Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus

Open access

Abstract

Fasting the Holy month of Ramadan constitutes one of the five pillars of the Muslim faith. Although there is some evidence that intermittent fasting during Ramadan may be of benefit in losing weight and cardiometabolic risk factors, there is no strong evidence these benefits apply to people with diabetes. The American Diabetes Association/European Association for the Study of Diabetes consensus recommendations emphasize the importance of patient factors and comorbidities when choosing diabetes medications including the presence of comorbidities, atherosclerotic cardiovascular disease, heart failure, chronic kidney disease, hypoglycemia risk, weight issues and costs. Structured education and pre-Ramadan counseing are key components to successful management of patients with diabetes. These should cover important aspects like glycemic targets, self-monitoring of blood glucose, diet, physical activity including Taraweeh prayers, medication and dose adjustment, side effects and when to break the fast. The decision cycle adapted for the specific situation of Ramadan provides an aid for such an assessment. Children with type 1 diabetes should strongly be advised not to fast due to the high risk of acute complications such as hypoglycemia and probably diabetic ketoacidosis (DKA), although there is very little evidence that DKA is increased in Ramadan. Pregnant women with diabetes or gestational diabetes should be advised to avoid fasting because of possible negative maternal and fetal outcomes. Hypoglycemia is a common concern during Ramadan fasting. To prevent hypoglycemic and hyperglycemic events, we recommend the adoption of diabetes self-management education and support principles. The use of the emerging technology and continuous glucose monitoring during Ramadan could help to recognize hypoglycemic and hyperglycemic complications related to omission and/or medication adjustment during fasting; however, the cost represents a significant barrier.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2020-001248

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Decision cycle for patient-centred glycemic management in Muslim patients during Ramadan. Modified and adopted from Davies et al.13 ASCVD, atherosclerotic cardiovascular disease; BD, twice a day; CKD, chronic kidney disease; DKA, diabetic ketoacidosis; HF, heart failure; HHS, hyperosmolar hyperglycemic state; MNT, medical nutrition therapy; OD, once a day; SMBG, self-monitoring of blood glucose.
Figure 1 Decision cycle for patient-centred glycemic management in Muslim patients during Ramadan. Modified and adopted from Davies et al.13 ASCVD, atherosclerotic cardiovascular disease; BD, twice a day; CKD, chronic kidney disease; DKA, diabetic ketoacidosis; HF, heart failure; HHS, hyperosmolar hyperglycemic state; MNT, medical nutrition therapy; OD, once a day; SMBG, self-monitoring of blood glucose.CC BY-NC · PubMed Central
Figure 2 Glucose-lowering medications use before and during Ramadan. Modified and adopted from Davies et al.13 *For intensification beyond dual therapy, choose option with lower risk of hypoglycemia. **Consider sulfonylurea (SU) or basal insulin with lower risk of hypoglycemia. ASCVD, atherosclerotic cardiovascular disease; CKD, chronic kidney disease; DKA, diabetic ketoacidosis; DPP4, dipeptidyl peptidase-4; GLP-1RA, glucagon-like peptide-1 receptor agonists; HbA1c, glycated hemoglobin; HF, heart failure; HHS, hyperosmolar hyperglycemic state; SGLT2i, sodium-glucose cotransporter-2 inhibitors; SMBG, self-monitoring of blood glucose; TZD, thiazolidinedione.
Figure 2 Glucose-lowering medications use before and during Ramadan. Modified and adopted from Davies et al.13 *For intensification beyond dual therapy, choose option with lower risk of hypoglycemia. **Consider sulfonylurea (SU) or basal insulin with lower risk of hypoglycemia. ASCVD, atherosclerotic cardiovascular disease; CKD, chronic kidney disease; DKA, diabetic ketoacidosis; DPP4, dipeptidyl peptidase-4; GLP-1RA, glucagon-like peptide-1 receptor agonists; HbA1c, glycated hemoglobin; HF, heart failure; HHS, hyperosmolar hyperglycemic state; SGLT2i, sodium-glucose cotransporter-2 inhibitors; SMBG, self-monitoring of blood glucose; TZD, thiazolidinedione.CC BY-NC · PubMed Central
Figure 3 Managing injectable therapy before and during Ramadan. Modified and adopted from Davies et al.13 Consider basal insulin with lower risk of hypoglycemia (degludec/glargine 300<glargine 100/detemir<NPH). BD, twice a day; GLP-1RA, glucagon-like peptide-1 receptor agonists; HbA1c, glycated hemoglobin; NPH, Neutral Protamine Hagedorn; OD, once a day; TDS, three times a day.
Figure 3 Managing injectable therapy before and during Ramadan. Modified and adopted from Davies et al.13 Consider basal insulin with lower risk of hypoglycemia (degludec/glargine 300<glargine 100/detemir<NPH). BD, twice a day; GLP-1RA, glucagon-like peptide-1 receptor agonists; HbA1c, glycated hemoglobin; NPH, Neutral Protamine Hagedorn; OD, once a day; TDS, three times a day.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 120 references

Research works printed but not linked: 4

  1. International Diabetes Federation . IDF diabetes atlas. 9th edition. Brussels, 2019. http://www.diabetesatlas.org
  2. Handy O , Yusof BNM , Reda WH , et al . Chapter 7: the Ramadan nutrition plan (RNP) for patients with diabetes, 2016. Available: http://www.daralliance.org/daralliance/
  3. Al-Mssallem, 2018, Consumption of dates among Saudi adults and its association with the prevalence of type 2 diabetes. Asian J, Clin. Nutr, 10, 58
  4. Bencharif, 2017, Impact of Ramadan fasting on energy intake and anthropometry of type 2 diabetics – study in 2 regions of the central highlands and southeastern Algeria, Journal of nutrition fasting & health, 5, 31

Cited by

See all 136

Metadata

Authors
Ibrahim, M., Davies, M. J., Ahmad, E., Annabi, F. A., Eckel, R. H., Ba-Essa, E. M., El Sayed, N. A., Hess Fischl, A., Houeiss, P., Iraqi, H., Khochtali, I., Khunti, K., Masood, S. N., Mimouni-Zerguini, S., Shera, S., Tuomilehto, J., & Umpierrez, G. E.
Affiliations
  • EDC Center for Diabetes Education, McDonough, Georgia, USA
  • University of Leicester (GB)
  • Islamic Hospital (JO)
  • University of Colorado Anschutz (US)
  • Dammam Medical Complex, Dammam, Saudi Arabia
  • Adult Diabetes, Joslin Diabetes Center, Boston, Massachusetts, USA
  • Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago Medicine, Chicago, Illinois, USA
  • American University of Beirut (LB)
  • Mohammed V University (MA)
  • Tunis University (TN)
  • Obstetrics & Gynecology, ISRA Medical University, Karachi, Sindh, Pakistan
  • Pierre & Marie Curie Center, University of Algiers, Algiers, Algeria
  • Diabetic Association of Pakistan, Karachi, Pakistan
  • Finnish Institute for Health and Welfare (FI)
  • Emory University (US)
Corresponding author
Ibrahim, Mahmoud
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2020-05
Volume
8
Issue
1
Pages
e001248
ISSN
2052-4897 (ISSN-L)
OpenAlex
W3021583569
Cited by
124
References
120
Citations by year
2026: 6 · 2025: 26 · 2024: 19 · 2023: 23 · 2022: 27 · 2021: 18 · 2020: 5
FWCI
2.33
Type
journal article
Language
en
Open access
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by-nc)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
Funders
  • National Institute for Health and Care Research
  • Department of Health and Social Care
  • NIHR Leicester Biomedical Research Centre
  • NIHR Leicester Clinical Research Facility
Topics
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
Ramadan fasting, diabetes management, intermittent fasting, hypoglycemia, diabetes self-management education, continuous glucose monitoring, type 1 diabetes in children, gestational diabetes mellitus, medication dose adjustment, glycemic targets, self-monitoring of blood glucose, diabetic ketoacidosis, financial barriers to care
MeSH terms
Blood Glucose, Child, Consensus Statements as Topic, Diabetes Mellitus, Fasting, Female, Humans, Hypoglycemia, Pregnancy, Blood Glucose Self-Monitoring, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. https://app.cochat.ai/papers/10.1136/bmjdrc-2020-001248
The paper
Ibrahim, M., Davies, M. J., Ahmad, E., Annabi, F. A., Eckel, R. H., Ba-Essa, E. M., El Sayed, N. A., Hess Fischl, A., Houeiss, P., Iraqi, H., Khochtali, I., Khunti, K., Masood, S. N., Mimouni-Zerguini, S., Shera, S., Tuomilehto, J., & Umpierrez, G. E. (2020). Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2020-001248

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.